This investigation validated the heightened expression of PDPN in astrocytes triggered by glioma growth and brain ischemia, suggesting that PDPN could be a novel cell surface marker for a distinct group of reactive astrocytes near gliomas and non-neoplastic brain lesions. The gene discussed is PDPN; the disease is brain ischemia.